Kristine McKinney

Title: The Innovative Contributions of Kristine McKinney

Introduction

Kristine McKinney is a prominent inventor based in Cambridge, MA (US). She has made significant strides in the field of immunotherapy, particularly through her work on mRNA compositions. Her innovative approach aims to enhance immune responses against cancer, showcasing her commitment to advancing medical science.

Latest Patents

Kristine McKinney holds 1 patent for her invention titled "Immunomodulatory therapeutic mRNA compositions encoding activating oncogene mutation peptides." This patent features compositions that include an mRNA encoding an activating oncogene mutation peptide and an mRNA that enhances immune responses. The methods described in her patent aim to stimulate anti-cancer immune responses, representing a crucial advancement in cancer treatment.

Career Highlights

McKinney is currently associated with ModernaTX, Inc., a leading biotechnology company known for its innovative approaches to vaccine development and therapeutics. Her work at ModernaTX, Inc. reflects her dedication to harnessing cutting-edge technology for the betterment of public health.

Collaborations

Throughout her career, Kristine has collaborated with notable colleagues, including Eric Yi-Chun Huang and Sze-Wah Tse. These partnerships have contributed to her success and the advancement of her research in immunotherapy.

Conclusion

Kristine McKinney's contributions to the field of immunotherapy through her innovative patent and work at ModernaTX, Inc. highlight her role as a leading inventor. Her efforts in developing mRNA compositions for cancer treatment are paving the way for future advancements in medical science.